<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Holmen Olofsson G</submitter><funding>Else og Mogens Wedell Wedellsborgs Fond</funding><funding>Fabrikant Einar Willumsens Mindelegat</funding><funding>Karen A. Tolstrups Fond</funding><funding>Dr.phil Ragna Rask-Nielsens Fond</funding><funding>Axel Muusfeldts Fond</funding><funding>Sundhedsstyrelsen</funding><funding>Familien Erichsens Mindefond</funding><funding>Neye Fond</funding><funding>Aase og Ejnar Danielsens Fond</funding><pagination>246</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8897734</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The increasing role of exercise training in cancer care is built on evidence that exercise can reduce side effects of treatment, improve physical functioning and quality of life. We and others have shown in mouse tumor models, that exercise leads to an adrenalin-mediated increased influx of T and NK cells into the tumor, altering the tumor microenvironment (TME) and leading to reduced tumor growth. These data suggest that exercise could improve immune responses against cancer cells by increase immune cell infiltration to the tumor and potentially having an impact on disease progression. Additionally, there are data to suggest that infiltration of T and NK cells into the TME is correlates with response to immune checkpoint inhibitors in patients. We have therefore initiat</pubmed_abstract><journal>BMC cancer</journal><pubmed_title>High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)-a randomized controlled trial.</pubmed_title><pmcid>PMC8897734</pmcid><funding_grant_id>2020-0412</funding_grant_id><funding_grant_id>2017-677</funding_grant_id><funding_grant_id>300.106-014</funding_grant_id><funding_grant_id>15265</funding_grant_id><funding_grant_id>05-0400-50</funding_grant_id><funding_grant_id>19-10-0273</funding_grant_id><funding_grant_id>9-21-2</funding_grant_id><funding_grant_id>05-0400-18</funding_grant_id><pubmed_authors>Horsted CB</pubmed_authors><pubmed_authors>Holmen Olofsson G</pubmed_authors><pubmed_authors>Nielsen DL</pubmed_authors><pubmed_authors>Lorentzen T</pubmed_authors><pubmed_authors>Heide-Ottosen L</pubmed_authors><pubmed_authors>Olsen AP</pubmed_authors><pubmed_authors>Christiansen AB</pubmed_authors><pubmed_authors>Thor Straten P</pubmed_authors><pubmed_authors>Persson GF</pubmed_authors><pubmed_authors>Engell-Noerregaard L</pubmed_authors><pubmed_authors>Mikkelsen MK</pubmed_authors><pubmed_authors>Ragle AM</pubmed_authors><pubmed_authors>Vinther A</pubmed_authors><pubmed_authors>Pedersen CMS</pubmed_authors></additional><is_claimable>false</is_claimable><name>High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)-a randomized controlled trial.</name><description>&lt;h4>Background&lt;/h4>The increasing role of exercise training in cancer care is built on evidence that exercise can reduce side effects of treatment, improve physical functioning and quality of life. We and others have shown in mouse tumor models, that exercise leads to an adrenalin-mediated increased influx of T and NK cells into the tumor, altering the tumor microenvironment (TME) and leading to reduced tumor growth. These data suggest that exercise could improve immune responses against cancer cells by increase immune cell infiltration to the tumor and potentially having an impact on disease progression. Additionally, there are data to suggest that infiltration of T and NK cells into the TME is correlates with response to immune checkpoint inhibitors in patients. We have therefore initiat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-05-18T12:35:09.25Z</modification><creation>2025-04-06T12:04:46.617Z</creation></dates><accession>S-EPMC8897734</accession><cross_references><pubmed>35247994</pubmed><doi>10.1186/s12885-022-09349-y</doi></cross_references></HashMap>